Clinical trials
Observational Influenza, Human trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 4 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 6 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 4 |
| Central Hospital, Nancy, France | 3 |
| Fondation Hôpital Saint-Joseph | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Association Clinique Thérapeutique Infantile du val de Marne | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux | 1 |
| Hoffmann-La Roche | 1 |
| Hospices Civils de Lyon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 23 |
| COVID-19 | 3 |
| Acute Lung Injury | 2 |
| Critical Illness | 2 |
| Gastroenteritis | 2 |
| Invasive Pulmonary Aspergillosis | 2 |
| Pneumonia | 2 |
| Respiratory Distress Syndrome | 2 |
| Respiratory Tract Infections | 2 |
| Aspergillosis | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.